Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B
- PMID: 40729424
- DOI: 10.1111/hae.70097
Management of Pregnancy, Delivery, and Postpartum in Italian Carriers and Women With Haemophilia A and B
Abstract
Introduction: Managing pregnancy in carriers/women with haemophilia involves four key objectives: preconception and prenatal care, minimizing maternal bleeding, choosing the delivery mode to reduce foetal/neonatal bleeding, and postpartum care. The optimal factor VIII/IX level at delivery and the best delivery method to mitigate maternal and foetal complications are still debated.
Aim: To share real-world clinical management in Italian haemophilia treatment centres.
Methods: In March-April 2023, members of the Italian Association of Hemophilia Centers "AICE" were invited to an online survey to collect information on the management of pregnancy, delivery, and postpartum in carriers/women with haemophilia.
Results: Thirty-three centres responded. Plasma FVIII/FIX levels are systematically evaluated in the third trimester, considering a threshold above 50 U/dL essential for safe delivery and neuraxial analgesia. Overall, the haematologic counselling on delivery mode generally aligns with obstetric indications in 73% of centres. In women who will give birth to a known affected male foetus, 55% rely on obstetric indication, while 24% suggest spontaneous delivery and 21% planned caesarean section. Excluding those which follow obstetric indication, natural delivery and planned caesarean section are recommended respectively by 40% and 60% when prenatal diagnosis is available or by 20% and 80% when not available. All centres agree to avoid instrumental delivery in affected male foetus or when prenatal diagnosis has not been made.
Conclusion: Multidisciplinary pregnancy management is recommended. Delivery mode choice is primarily driven by ensuring the newborn's maximum protection. However, the use of caesarean section should also be weighted according to the mother's risk profile.
Keywords: delivery; haemophilia; multidisciplinary management; newborn; pregnancy; women.
© 2025 John Wiley & Sons Ltd.
References
-
- P. H. Bolton‐Maggs and K. J. Pasi, “Haemophilias A and B,” Lancet 361 (2003): 1801–1809.
-
- G. C. White, F. Rosendaal, L. M. Aledort, et al., “Definitions in Hemophilia Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis,” Thromb Haemost 85 (2001): 560.
-
- K. P. M. van Galen, d'R. Oiron, P. James, et al., “A New Hemophilia Carrier Nomenclature to Define Hemophilia in Women and Girls: Communication From the SSC of the ISTH,” Journal of Thrombosis and Haemostasis 19, no. 8 (2021): 1883–1887.
-
- I. Plug, E. P. Mauser‐Bunschoten, A. Bröcker‐Vriends, et al., “Bleeding in Carriers of Hemophilia,” Blood 108 (2006): 52–56.
-
- A. C. Goodeve, “Hemophilia B: Molecular Pathogenesis and Mutation Analysis,” Journal of Thrombosis and Haemostasis 13 (2015): 1184–1195.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous